Pfizer’s Help With Heart Disease

Heart disease is becoming more and more common among the public regardless of age, race, and background.

Mild heart disease should be treated just the same way as any other life threatening disease. Studies released today show that Pfizer Inc. (NYSE:PFE) produced Inspra has helped many with mild heart disease. The drug is used in combination with other general medication to reduce the risk of any severe heart problems. Pfizer is known to work with the American Heart Association to provide some of the best medication out there and this just shows their commitment to help reduce heart disease.

« Return to Stock Market News «

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.